Company Filing History:
2 out of 870 
2 out of 1,745 
1 out of 832,912 Years Active: 2000-2010
Title: Maryline Mancini: Innovator in Hepatitis B Vaccine Development
Introduction
Maryline Mancini is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the development of vaccines for hepatitis B. With a total of 3 patents to her name, her work has the potential to impact public health significantly.
Latest Patents
Mancini's latest patents include a nucleotide vector and a composition containing such a vector, aimed at immunization against hepatitis. One of her notable inventions is a nucleotide vector comprising at least one gene or complementary DNA coding for a portion of the hepatitis B virus. This vector is designed to express the gene in muscle cells, potentially breaking T cell tolerance to the virus's surface antigens. Additionally, her vaccine preparation involves injecting bare DNA into a host that has been treated to induce coagulating necrosis of muscle fibers, enhancing the immunization process against hepatitis B.
Career Highlights
Throughout her career, Maryline Mancini has worked with esteemed institutions such as the Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. Her research has focused on innovative approaches to vaccine development, particularly in addressing chronic hepatitis B virus infections.
Collaborations
Mancini has collaborated with notable professionals in her field, including Marie-Louise Michel. Their joint efforts have contributed to advancements in vaccine research and development.
Conclusion
Maryline Mancini's work in the field of hepatitis B vaccine development showcases her innovative spirit and dedication to improving public health. Her contributions through her patents and collaborations highlight the importance of research in combating viral infections.